The transcription factor nuclear factor κ-light-chain enhancer of activated B cells (NF-κB) plays a major role in mediating inflammation and immune function, with enhanced activity seen in the kidneys of diabetic patients and in preclinical models of diabetes [6, 7]. This evidence concerns the gene NFKB1 and diabetes mellitus.